Managing Clinical Trials for Alzheimer’s disease during the COVID-19 crisis: experience at Fundació ACE in Barcelona, Spain

Manuscript Number: 

20-0750R2

Author(s): 
Carla Abdelnour, Nuria Aguilera, Alba Benaque, Mercè Boada, Mar Buendía, Anna Calvet, Laia Cañada, Rosario Cuevas, Susana Diego, Ester Esteban, Antonio Gonzalez-Perez, Miren Gurruchaga, Marta Ibarria, Sara Jofresa, Asunción Lafuente, Marta Marquié, Laura Montrreal, Adela Orellana, Ana Pancho, Alba Pérez-Cordón, Agustín Ruiz, Lluís Tárraga, Laura de Jorge

Disclosures

Carla Abdelnour

  • Consulting Fees:
    Advisory Board for NCP-5, Renew Research, LLC
    Lecture Fees:
    Lecture fee for La Roche-Hoffman Lecture fee for Zambon Lecture fee for Schwabe

Antonio Gonzalez-Perez

  • Nothing to Disclose

Nuria Aguilera

  • Disclosure not yet completed

Alba Benaque

  • Disclosure not yet completed

Mercè Boada

  • Disclosure not yet completed

Mar Buendía

  • Disclosure not yet completed

Anna Calvet

  • Disclosure not yet completed

Laia Cañada

  • Disclosure not yet completed

Rosario Cuevas

  • Disclosure not yet completed

Susana Diego

  • Disclosure not yet completed

Ester Esteban

  • Disclosure not yet completed

Miren Gurruchaga

  • Disclosure not yet completed

Marta Ibarria

  • Disclosure not yet completed

Sara Jofresa

  • Disclosure not yet completed

Asunción Lafuente

  • Disclosure not yet completed

Marta Marquié

  • Disclosure not yet completed

Laura Montrreal

  • Disclosure not yet completed

Adela Orellana

  • Disclosure not yet completed

Ana Pancho

  • Disclosure not yet completed

Alba Pérez-Cordón

  • Disclosure not yet completed

Agustín Ruiz

  • Disclosure not yet completed

Lluís Tárraga

  • Disclosure not yet completed

Laura de Jorge

  • Disclosure not yet completed